NCT06374615 Insights Into Tick-Borne Diseases: a Study From an Endemic Area of Northern Italy
| NCT ID | NCT06374615 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Sacro Cuore Don Calabria di Negrar |
| Condition | Tick-Borne Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 384 participants |
| Start Date | 2024-03-25 |
| Primary Completion | 2029-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 384 participants in total. It began in 2024-03-25 with a primary completion date of 2029-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a monocentric, experimental, non-pharmacological and non-device no profit study. The study is experimental because all the visits and blood withdrawals foreseen by the protocol do not fall within the normal clinical practice.
Eligibility Criteria
Inclusion Criteria: * all individuals aged \> 8 years presenting for tick removal. * Individuals providing signed informed consent. Exclusion Criteria: * tick not available for analysis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06374615 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, studying Tick-Borne Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06374615 currently recruiting?
Yes, NCT06374615 is actively recruiting participants. Contact the research team at ricerca.clinica@sacrocuore.it for enrollment information.
Where is the NCT06374615 trial being conducted?
This trial is being conducted at Negrar, Italy.
Who is sponsoring the NCT06374615 clinical trial?
NCT06374615 is sponsored by IRCCS Sacro Cuore Don Calabria di Negrar. The trial plans to enroll 384 participants.